Sattva Sukun Lifecare Ltd - 539519 - Notice Of EOGM
Sattva Sukun Lifecare's EGM approved changing the company name to Tavexia Lifecare. The meeting also approved a significant expansion of its main business objects to include pharmaceuticals, biotechnology, contract manufacturing, and R&D activities, signaling a strategic pivot.
Jun 30 2026 16:46:45
Sattva Sukun Lifecare Ltd - 539519 - Update On Outcome Of Board Meeting
Sattva Sukun Lifecare board approved a change in the company's name and altered its Memorandum of Association. This strategic move expands the company's business scope into chemicals, pharmaceuticals, nutraceuticals, biotechnology, and R&D activities, pending shareholder approval.
Jun 30 2026 16:37:55
Sattva Sukun Lifecare Ltd - 539519 - Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of Association
Sattva Sukun Lifecare's Board approved changing the company name and amending its Memorandum of Association. These changes will diversify the company's business into chemicals, pharmaceuticals, and biotechnology, aligning corporate identity with new business activities.
Jun 30 2026 14:31:14
Sattva Sukun Lifecare Ltd - 539519 - Board Meeting Outcome for Outcome Of Board Meeting
Sattva Sukun Lifecare board approved changing its name and significantly expanding its object clause. This strategic shift will allow the company to venture into pharmaceuticals, biotechnology, and chemical manufacturing, trading, and contract research services.
Jun 30 2026 14:20:32
Sattva Sukun Lifecare Ltd - 539519 - Board Meeting Intimation for Intimation Of The Adjournment/Rescheduling Of The Board Meeting
Sattva Sukun Lifecare has rescheduled its Board Meeting from June 29, 2026, to June 30, 2026. The change is to allow for the finalization of pending information and documents related to the agenda items.
Jun 29 2026 18:43:05
Sattva Sukun Lifecare Ltd - 539519 - Board Meeting Intimation for Intimation Of Board Meeting
Sattva Sukun Lifecare's Board of Directors is scheduled to meet on June 29, 2026. The agenda includes considering changes to the company's Memorandum of Association (Object and Name Clauses) and the regularization of two Non-Executive Independent Directors. These changes require shareholder approval and an EGM.
Jun 24 2026 18:56:12
Read More